Womack Army Medical Center is a United States Army-run military hospital that is located on Fort Bragg near Fayetteville, North Carolina. The facility is named for Medal of Honor recipient Bryant H. Womack.

During the past decade, Womack Army Medical Center - Pulmonary and Respiratory Services conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Womack Army Medical Center - Pulmonary and Respiratory Services" are "COVID-19" (3 trials). Many other conditions were trialed in "Womack Army Medical Center - Pulmonary and Respiratory Services" in a lesser frequency.

Most popular intervention types in "Womack Army Medical Center - Pulmonary and Respiratory Services" are "Drug" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Remdesivir" (3 trials), "Baricitinib" (2 trials), "Dexamethasone" (1 trials) and "Interferon beta-1a" (1 trials). Other intervention names were less common.

The vast majority of trials in "Womack Army Medical Center - Pulmonary and Respiratory Services" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Womack Army Medical Center - Pulmonary and Respiratory Services". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Womack Army Medical Center - Pulmonary and Respiratory Services, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Womack Army Medical Center - Pulmonary and Respiratory Services, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".